A Phase I, Single-blind, Randomized Study of the Safety and Efficacy of Cellularized Integra® Using Autologous Burn-derived Stem Cells
Clinical trial NCT05344521 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05344521
- Sponsor
- Hamilton Health Sciences Corporation
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-01
- Primary completion
- 2026-02-01
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.